Quercetin promotes glioma growth in a rat model

Food and Chemical Toxicology

Volumn 63, Issue , 2014, Pages 205-211

  Zamin, Lauren L ^a,b   Filippi Chiela, Eduardo C ^a   Vargas, Jose ^a   Demartini, Diogo Ribeiro ^a   Meurer, Luise ^c   Souza, Ana Paula ^d   Bonorino, Cristina ^d   Salbego, Christianne ^a   Lenz, Guido ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DA FRONTEIRA SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Glioblastoma; In vivo glioma model; Quercetin; Tumor cell growth

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; QUERCETIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLIOMA; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; RAT; TUMOR VOLUME;

RATTUS;

ALANINE AMINOTRANSFERASE; ALT; ASPARTATE AMINOTRANSFERASE; AST; C; CONTROL; DMEM; DULBECCO'S MODIFIED EAGLE'S MEDIUM; GBM; GLIOBLASTOMA; IN VIVO GLIOMA MODEL; PHA; PHYTOHAEMAGGLUTININ; QUER; QUERCETIN; TUMOR CELL GROWTH; Γ-GLUTAMYLTRANSFERASE; Γ-GT;

ANIMALS; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GLIOMA; MALE; QUERCETIN; RATS; RATS, WISTAR;

EID: 84888794524     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.11.002     Document Type: Article

References (74)

1. Bernardi A., Braganhol E., Jager E., Figueiro F., Edelweiss M.I., Pohlmann A.R., Guterres S.S., Battastini A.M.O. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Cancer Lett. 2009, 281:53-63.
2. Bischoff S.C. Quercetin: potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:733-740.
3. Bolli A., Marino M., Rimbach G., Fanali G., Fasano M., Ascenzi P. Flavonoid binding to human serum albumin. Biochem. Biophys. Res. Commun. 2010, 398:444-449.
4. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
5. Braganhol E., Huppes D., Bernardi A., Wink M.R., Lenz G., Battastini A.M. A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model. Cell Tissue Res. 2009, 335(2):331-340.
6. Braganhol E., Zamin L.L., Canedo A.D., Horn F., Tamajusuku A.S., Wink M.R., Salbego C., Battastini A.M. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs 2006, 17(6):663-671.
7. Casagrande F., Darbon J.M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem. Pharmacol. 2001, 61:1205-1215.
8. Chan S.T., Yang N.C., Huang C.S., Liao J.W., Yeh S.L. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. Plos One 2013, 8(1):e54255.
9. Chekhonin V.P., Baklaushev V.P., Yusubalieva G.M., Pavlov K.A., Ukhova O.V., Gurina O.I. Modeling and immunohistochemical analysis of C6 glioma in viv. Bull. Exp. Biol. Med. 2007, 143(4):501-509.
10. Chen C., Zhou J., Ji C. Quercetin: a potential drug to reverse multidrug resistance. Life Sci. 2010, 87(11-12):333-338.
11. Cho J.Y., Kim I.S., Jang Y.H., Kim A.R., Lee S.R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci. Lett. 2006, 404:330-335.
12. Chung S., Yao H., Caito S., Hwang J.W., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501(1):79-90.
13. Cos P., Calomme M., Sindambiwe J.-B., De Brune T., Cimanga K., Pieters L., Vlietinck A.J., van den Berghe D. Cytotoxic and lipid peroxidation inhibiting activity of flavonoids. Planta Med. 2001, 67:515-519.
14. Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012, 143(2):383-396.
15. Damianaki A., Bakogeorgou E., Kampa M., Notas G., Hatzoglou A., Panagiotou S., Gemetzi C., Kouroumalis E., Martin P.M., Castanas E. Potent inhibitory action of red wine polyphonols on human breast cancer cells. J. Cell Biochem. 2000, 78:429-441.
16. Day A.J., Mellon F., Barron D., Sarrazin G., Morgan M.R., Williamson G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res. 2001, 35:941-952.
17. Donnini S., Finetti F., Lusini L., Morbidelli L., Cheynier V., Barron D., Williamson G., Waltenberger J., Ziche M. Divergent effects of quercetin conjugates on angiogenesis. Br. J. Nutr. 2006, 95:1016-1023.
18. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., Wagner A.E., Frank J., Schrezenmeir J., Rimbach G., et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nut. 2009, 102:1065-1074.
19. Fan P.S., Gu Z.L., Sheng R., Liang Z.Q., Wang X.X., Zhu Y. Inhibitory effect of quercetin on proliferation of human microvascular endothelial cells in vitro. Acta Pharmacol. Sin. 2003, 24:1231-1234.
20. Ferry D.R., Smith A., Malkhandi J., Fyfe D.W., deTakats P.G., Anderson D., Baker J., Kerr D.J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 1996, 2(4):659-668.
21. Frozza R.L., Bernardi A., Paese K., Hoppe J.B., Silva T., Battastini A.M.O., Pohlmann A.R., Guterres S.S., Salbego C. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol. 2010, 6:1-10.
22. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., et al. Malignant astrocyticglioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21:2683-2710.
23. Gulati N., Laudet B., Zohrabian V.M., Murali R., Jhanwar-Uniyal M. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K Akt/PKB pathway. Anticancer Res. 2006, 26(2A):1177-1181.
24. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 1965, 37:614-636.
25. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993, 342:1007-1011.
26. Hosokawa N., Hosokawa Y., Sakai T., Yoshida M., Aoike A., Kawai K., Nishino H., Fukushima M. Inhibitory effect of quercetin on the synthesis of a possible cell-cycle-related 17kDa protein in human colon cancer cells. Int. J. Cancer 1990, 45:1119-1124.
27. Igura K., Ohta T., Kuroda Y., Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001, 171:11-16.
28. Indap M.A., Bhosle S.C., Shinde A.D., Barkume M.S., Ingle A.D. Tumour response to quercetin, a bioflavonoid with some promises in therapies. Indian J. Pharm. Sci. 2006, 68:570-574.
29. Jakubowicz-Gil J., Langner E., Wertel I., Piersiak T., Rzeski W. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem. Biol. Interact. 2010, 188(1):190-203.
30. Joshi D., Naidu P.S., Singh A., Kulkarni S.K. Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J. Med. Food 2005, 8(3):392-396.
31. Kaczarek E., Zapf S., Bouterfa H., Tonn J.R.C., Westphal M., Giese A. Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype. Int. J. Dev. Neur. 1999, 17:625-641.
32. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer 2000, 37:223-233.
33. Kleihues P., Burger P.C., Collins V.P., Newcomb E.W., Ohgaki H., Cavenee W.K. Pathology and genetics of tumours of the central nervous system. World Health Organization Classification of Tumours 2000, 6-69. IARC Press, Lyon. P. Kleihues, W.K. Cavenee (Eds.).
34. Kleihues P., Cavenee W. Pathology and genetics of tumors of the nervous system 2000, IARC Press, Lyon.
35. Kuntz S., Wenzel U., Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 1999, 38:133-142.
36. Li D., Yang K., Li J.S., Ke X.Y., Duan Y., Du R., Song P., Yu K.F., Ren W., Huang D., Li X.H., Hu X., Zhang X., Zhang Q. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings. Int. J. Nanomed. 2012, 7:6105-6114.
37. Louis D.N. Molecular pathology of malignant gliomas. Annu. Rev. Pathol. Mech. Dis. 2006, 1:97-117.
38. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C., Newmark H.L., Bertagnolli M.M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatouspolyposis. Carcinogenesis 2000, 21:921-927.
39. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 2000, 42(4):673-751.
40. Molina M.F., Sanchez-Reus I., Iglesias I., Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol. Pharm. Bull. 2003, 26(10):1398-1402.
41. Moreira A.J., Fraga C., Alonso M., Collado P.S., Zetller C., Marroni C., Marroni N., Gonzalez-Gallego J. Quercetin prevents oxidative stress and NF-kB activation in gastric mucosa of portal hypertensive rats. Biochem. Pharmacol. 2004, 68:1939-1946.
42. Morrone F.B., Oliveira D.L., Gamermann P., Stella J., Wofchuk S., Wink M.R., Meurer L., Edelweiss M.I.A., Lenz G., Battastini A.M.O. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 2006, 6:226-236.
43. Morrow D.M.P., Fitzsimmons P.E.E., Chopra M., McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mut. Res. 2001, 480-481:269-276.
44. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65:55-63.
45. Motta A., Schmitz C., Rodrigues L., Ribeiro F., Teixeira C., Detanico T., Bonan C., Zwickey H., Bonorino C. Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro. Immunology 2007, 121:462-472.
46. Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008, 269:315-325.
47. Murota K., Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 2003, 417:12-17.
48. Palma L., Lorenzo N.D., Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J. Neurosurg. 1978, 49(6):854-861.
49. Pamukcu A.M., Yalciner S., Hatcher J.F., Bryan G.T. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res. 1980, 40:3468-3472.
50. Pawlikowska-Pawlega B., Jakubowicz-Gil J., Rzymowska J., Gawron A. The effect of quercetin on apoptosis and necrosis induction in human colon adenocarcinoma cell line LS180. Folia Histochem. Cytobiol. 2001, 39:217-218.
51. Ranelletti F.O., Maggiano N., Serra F.G., Ricci R., Larocca L.M., Lanza P., Scambia G., Fattorossi A., Capelli A., Piantelli M. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int. J. Cancer 2000, 85:438-445.
52. Rawel H.M., Meidtner K., Kroll J. Binding of selected phenolic compounds to proteins. J. Agric. Food Chem. 2005, 53:4228-4235.
53. Rosner K., Ropke C., Pless V., Skovgaard G.L. Late type apoptosis and apoptosis free lethal effect of quercetin in human melanoma. Biosci. Biotechnol. Biochem. 2006, 70(9):2169-2177.
54. Russel D.S., Rubenstein L.J. Pathology of tumors of the nervous system 1989, Williams & Wilkins, Baltimore.
55. Russo M., Spagnuolo C., Tedesco I., Bilotto S., Russo G.L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 2012, 83(1):6-15.
56. Sathornsumetee S., Rich J.N., Reardon D.A. Diagnosis and treatment of high grade astrocytoma. Neurol. Clin. 2007, 25:1111-1139.
57. Schiffer D. Brain tumors. Biology, Pathology, and Clinical References 1997, Springer, New York, Berlin, Heidelberg.
58. Schlachterman A., Valle F., Wall K.M., Azios N.G., Castillo L., Morell L., Washington A.V., Cubano L.A., Dharmawardhane S.F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl. Oncol. 2008, 1(1):19-27.
59. Seibert H., Maser E., Schweda K., Seibert S., Gülden M. Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cells. Food Chem. Toxicol. 2011, 49(9):2398-2407.
60. Singh B., Mense S.M., Bhat N.K., Putty S., Guthiel W.A., Remotti F., Bhat H.K. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol. Appl. Pharmacol. 2010, 247(2):83-90.
61. Spencer J.P.E., Rice-Evans C., Williams R.J. Modulation of prosurvival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem. 2003, 278:34783-34789.
62. Sun M., Nie S., Pan X., Zhang R., Fan Z., Wang S. Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf. B. Biointerfaces 2013, 113C:15-24.
63. Suzuki Y., Ishihara M., Segami T., Ito M. Anti-ulcer effects of antioxidants, quercetina, a-tocopherol, nifedipine and tetracycline in rats. Jpn. J. Pharmacol. 1998, 78:435-441.
64. Takano T., Lin J.H.C., Arcuino G., Gao Q., Yang J., Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat. Med. 2001, 7:1010-1015.
65. Tan W.F., Lin L.P., Li M.H., Zhang Y.X., Tong Y.G., Xiao D., Ding J. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur. J. Pharmacol. 2003, 459:255-262.
66. Verschoyle R.D., Steward W.P., Gescher A.J. Putative cancer chemopreventive agents of dietary origin-how safe are they?. Nutr. Cancer 2007, 59(2):152-162.
67. Vidya Priyadarsini R., Senthil Murugan R., Maitreyi S., Ramalingam K., Karunagaran D., Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur. J. Pharmacol. 2010, 649(1-3):84-91.
68. Yamasaki T., Handa H., Yamashita J., Namba Y., Hanaoka M. Characteristic immunological responses to an experimental mouse brain tumor. Cancer Res. 1983, 43(10):4610-4617.
69. Yoshida M., Sakai T., Hosokawa N., Marui N., Matsumoto K., Fujioka A., Nishino H., Aoike A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 1990, 260:10-13.
70. Wilson J.D., Broaddus W.C., Dorn H.C., Fatouros P.P., Chalfant C.E., Shultz M.D. Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme. Bioconjug. Chem. 2012, 23(9):1873-1880.
71. Wood G.W., Morantz R.A. In vitro reversal of depressed T lymphocyte function in the peripheral blood of brain tumor patients. J. Natl. Cancer Inst. 1982, 68(1):27-33.
72. Wood G.W., Morantz R.A. Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells. J. Neurooncol. 1983, 1(2):87-94.
73. Zamin L.L., Filippi-Chiela E.C., Dillenburg-Pilla P., Horn F., Salbego C., Lenz G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 2009, 100:1655-1662.
74. Zhang Q., Zhao X.-H., Wang Z.-J. Cytotoxicity of flavones and flavonols to a human esophagal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro 2009, 23:797-807.